IM Cannabis (IMCC) Long-Term Deferred Tax (2019 - 2023)
IM Cannabis' (IMCC) quarterly Long-Term Deferred Tax came in at $483362.9 in Q3 2023, up 16.1% year-on-year from $416343.2 in Q3 2022, and down 13.31% quarter-over-quarter from $557594.9 in Q2 2023.
IM Cannabis (IMCC) Long-Term Deferred Tax (2019 - 2023) Analysis & Trends
IM Cannabis' Long-Term Deferred Tax history runs 5 years deep, the most recent figure standing at $483362.9 for Q3 2023.
- On a quarterly basis, Long-Term Deferred Tax rose 16.1% year-over-year to $483362.9 in Q3 2023; TTM through Sep 2023 was $483362.9, a 16.1% increase from a year earlier, with the FY2022 full-year figure at $586873.7, up 4496.7% from the prior year.
- Long-Term Deferred Tax declined to $483362.9 in Q3 2023 per IMCC's latest filing, from $557594.9 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $609509.8 in Q1 2023 and bottomed at $12693.4 in Q4 2021.
- The 5-year median for Long-Term Deferred Tax is $476429.8 (2021), against an average of $398677.7.
- Across the five-year window, Long-Term Deferred Tax plunged 97.85% in 2021 and surged 4328.33% in 2022, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $67417.4 in 2019, then jumped by 774.95% to $589865.0 in 2020, then plunged by 97.85% to $12693.4 in 2021, then jumped by 4328.33% to $562104.3 in 2022, then decreased by 14.01% to $483362.9 in 2023.
- Per Business Quant, the three latest IMCC Long-Term Deferred Tax figures stand at $483362.9 (Q3 2023), $557594.9 (Q2 2023), and $609509.8 (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 483,362.94 |
| Jun 30, 2023 | 557,594.90 |
| Mar 31, 2023 | 609,509.81 |
| Dec 31, 2022 | 562,104.34 |
| Sep 30, 2022 | 416,343.21 |
| Jun 30, 2022 | 532,567.30 |
| Mar 31, 2022 | 280,263.77 |
| Dec 31, 2021 | 12,693.38 |
| Sep 30, 2021 | 271,687.98 |
| Jun 30, 2021 | 322,970.28 |
| Mar 31, 2021 | 476,429.77 |
| Dec 31, 2020 | 589,865.04 |
| Dec 31, 2019 | 67,417.35 |